Abstract
This chapter details all aspects of the general principles of palliative care for advanced stage cholangiocarcinoma patients. These include symptoms management, communication guide, advance care planning, and management for bereavement. Surgical and intervention techniques of palliative biliary drainage are described in detail for patients with obstructive jaundice with advanced stage CCA. Additionally, details are provided regarding the establishment of a multidisciplinary palliative care team which is critical to provide the most appropriate multimodal treatment for good quality of life and survival of patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shirabe K, Mano Y, Taketomi A, Soejima Y, Uchiyama H, Aishima S et al (2010) Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index. Ann Surg Oncol 17(7):1816–1822
Nishihara Y, Aishima S, Hayashi A, Iguchi T, Fujita N, Taketomi A et al (2009) CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma. Histopathology 55(4):423–431
Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM et al (2017) Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update. J Clin Oncol 35(1):96–112
Pairojkul S, Thongkhamcharoen R, Raksasataya A, Sorasit C, Nakawiro P, Sudsa S et al (2021) Integration of specialist palliative care into tertiary hospitals: a multicenter point prevalence survey from Thailand. Palliat Med Rep 2(1):272–279
Eagan A, Mishra M, Bangerter L (2017) Salzburg global seminar, Session Report 562: rethinking care toward the end of life
Gomez-Batiste X, Murray SA, Thomas K, Blay C, Boyd K, Moine S et al (2017) Comprehensive and integrated palliative care for people with advanced chronic conditions: an update from several European initiatives and recommendations for policy. J Pain Symptom Manage 53(3):509–517
World Health Organization (2021) Assessing the development of palliative care worldwide: a set of actionable indicators
Kaasa S, Loge JH, Aapro M, Albreht T, Anderson R, Bruera E et al (2018) Integration of oncology and palliative care: a lancet oncology commission. Lancet Oncol 19(11):e588–e653
Stjernsward J, Foley KM, Ferris FD (2007) The public health strategy for palliative care. J Pain Symptom Manage 33(5):486–493
Henderson JD, Boyle A, Herx L, Alexiadis A, Barwich D, Connidis S et al (2019) Staffing a specialist palliative care service, a team-based approach: expert consensus white paper. J Palliat Med 22(11):1318–1323
Kamal AH, Bowman B, Ritchie CS (2019) Identifying palliative care champions to promote high-quality care to those with serious illness. J Am Geriatr Soc 67(S2):S461–S467
Murray S, Boyd K (2011) Using the “surprise question” can identify people with advanced heart failure and COPD who would benefit from a palliative care approach. Palliat Med 25:382
Moroni M, Zocchi D, Bolognesi D, Abernethy A, Rondelli R, Savorani G et al (2014) The “surprise” question in advanced cancer patients: a prospective study among general practitioners. Palliat Med 28(7):959–964
White N, Kupeli N, Vickerstaff V, Stone P (2017) How accurate is the ‘Surprise question’ at identifying patients at the end of life? A systematic review and meta-analysis. BMC Med 15(1):139
Downar J, Goldman R, Pinto R, Englesakis M, Adhikari NK (2017) The “surprise question” for predicting death in seriously ill patients: a systematic review and meta-analysis. CMAJ 189(13):E484–E493
Aishima S, Matsuura S, Terashi T, Taguchi K, Shimada M, Maehara Y et al (2004) Aberrant expression of laminin gamma 2 chain and its prognostic significance in intrahepatic cholangiocarcinoma according to growth morphology. Mod Pathol 17(8):938–945
Dunn GP (2001) Patient assessment in palliative care: how to see the “big picture” and what to do when “there is no more we can do.” J Am Coll Surg 193(5):565–573
Hui D, Bruera E (2017) The edmonton symptom assessment system 25 years later: past, present, and future developments. J Pain Symptom Manage 53(3):630–643
Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9
Seniors Health—Edmonton Zone Regional Palliative Care Program (2010) Guidelines for using the revised Edmonton symptom assessment system (ESAS-r)
Watanabe SM, Nekolaichuk C, Beaumont C, Johnson L, Myers J, Strasser F (2011) A multicenter study comparing two numerical versions of the Edmonton symptom assessment system in palliative care patients. J Pain Symptom Manage 41(2):456–468
Kelley AS, Morrison RS (2015) Palliative care for the seriously Ill. N Engl J Med 373(8):747–755
Somjaivong B, Thanasilp S, Preechawong S, Sloan R (2011) The influence of symptoms, social support, uncertainty, and coping on health-related quality of life among cholangiocarcinoma patients in northeast Thailand. Cancer Nurs 34(6):434–442
WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents. Geneva: World Health Organization 2018 Available from: https://www.ncbi.nlm.nih.gov/books/NBK537492/
Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N et al (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13(2):e58-68
Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J et al (2012) An official American thoracic society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 185(4):435–452
Pereira JL (2008) The pallium palliative pocketbook: a peer-reviewed, reference resource: pallium project
Mercadante S, Marinangeli F, Masedu F, Valenti M, Russo D, Ursini L et al (2018) Hyoscine Butylbromide for the management of death rattle: sooner rather than later. J Pain Symptom Manage 56(6):902–907
Taguchi K, Aishima S, Asayama Y, Kajiyama K, Kinukawa N, Shimada M et al (2001) The role of p27kip1 protein expression on the biological behavior of intrahepatic cholangiocarcinoma. Hepatology 33(5):1118–1123
Ratanasuwan P, Raksasataya A (2019) Update handbook for palliative care guidelines NHS, U.K. Khon Kaen, Klungnana Vitthaya Press, pp 1–200
Raksasataya A (2021) Textbook of palliative care, 1st edn. Thai palliative care society, Bangkok, pp 215–223
Abrams DI (2018) The therapeutic effects of Cannabis and cannabinoids: an update from the National Academies of sciences, engineering and medicine report. Eur J Intern Med 49:7–11
Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP (2000) SPIKES-a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist 5(4):302–311
Tulsky J, Schapira L (2008) Communication: what do patients want and need? J Oncol Pract 4(5):249–253
Sudore RL, Lum HD, You JJ, Hanson LC, Meier DE, Pantilat SZ, et al. (2017) Defining advance care planning for adults: a consensus definition from a multidisciplinary Delphi panel. J Pain Symptom Manage 53(5):821–32 e1
Rietjens J, Korfage I, Seymour J. Communication and palliative medicine. In: Cherny NI, Fallon MT, Kaasa S, Portenoy RK, Currow DC (eds) Oxford textbook of palliative medicine. 6th ed. New York, USA, Oxford University Press
Boyd K (2021) RED-MAP framework: the University of Edinburgh. Available from: https://www.spict.org.uk/red-map/
Bereavement KD (2021) In: Cherny NI, Fallon MT, Kaasa S, Portenoy RK, Currow DC (eds) Oxford textbook of palliative medicine, 6th edn. Oxford University Press, New York, USA, pp 773–784
Zhao XQ, Dong JH, Jiang K, Huang XQ, Zhang WZ (2015) Comparison of percutaneous transhepatic biliary drainage and endoscopic biliary drainage in the management of malignant biliary tract obstruction: a meta-analysis. Digestive Endoscopy: Official J Japan Gastroenterol Endoscopy Soc 27(1):137–145
Zhang GY, Li WT, Peng WJ, Li GD, He XH, Xu LC (2014) Clinical outcomes and prediction of survival following percutaneous biliary drainage for malignant obstructive jaundice. Oncol Lett 7(4):1185–1190
Bai AG, Zheng CS, Zhou GF, Liang HM, Feng GS (2010) Comparison of the therapeutic effects of PTBD and PTBS in treatment of malignant obstructive jaundice. Zhonghua zhong liu za zhi [Chinese J Oncol] 32(6):456–458
Sangchan A, Kongkasame W, Pugkhem A, Jenwitheesuk K, Mairiang P (2012) Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial. Gastrointest Endosc 76(1):93–99
Sangchan A, Chaiyakunapruk N, Supakankunti S, Pugkhem A, Mairiang P (2014) Cost utility analysis of endoscopic biliary stent in unresectable hilar cholangiocarcinoma: decision analytic modeling approach. Hepatogastroenterology 61(133):1175–1181
Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, Khor CJ, Ponnudurai R, Moon JH et al (2013) Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol 28(4):593–607
Yarmohammadi H, Covey AM (2016) Percutaneous biliary interventions and complications in malignant bile duct obstruction. Chin Clin Oncol 5(5):68
Inal M, Aksungur E, Akgul E, Oguz M, Seydaoglu G (2003) Percutaneous placement of metallic stents in malignant biliary obstruction: one-stage or two-stage procedure? Pre-dilate or not? Cardiovasc Intervent Radiol 26(1):40–45
Sohn SH, Park JH, Kim KH, Kim TN (2017) Complications and management of forgotten long-term biliary stents. World J Gastroenterol 23(4):622–628
Liberato MJ, Canena JM (2012) Endoscopic stenting for hilar cholangiocarcinoma: efficacy of unilateral and bilateral placement of plastic and metal stents in a retrospective review of 480 patients. BMC Gastroenterol 12:103
Schmidt A, Riecken B, Rische S, Klinger C, Jakobs R, Bechtler M, et al. Wing-shaped plastic stents versus self-expandable metal stents for palliative drainage of malignant distal biliary obstruction: a randomized multicenter study. Endoscopy 47(5):430–6
Ridtitid W, Rerknimitr R (2012) Management of an occluded biliary metallic stent. World J Gastrointest Endosc 4(5):157–161
Ridtitid W, Rerknimitr R, Janchai A, Kongkam P, Treeprasertsuk S, Kullavanijaya P (2010) Outcome of second interventions for occluded metallic stents in patients with malignant biliary obstruction. Surg Endosc 24(9):2216–2220
Kang H, Chung MJ, Cho IR, Jo JH, Lee HS, Park JY et al (2021) Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIAL. Surg Endosc 35(1):63–73
Witzigmann H, Lang H, Lauer H (2008) Guidelines for palliative surgery of cholangiocarcinoma. HPB (Oxford) 10(3):154–160
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Raksasataya, A., Ahooja, A., Krangbunkrong, V., Jareanrat, A., Titapun, A., Khuntikeo, N. (2023). Palliative Care in Cholangiocarcinoma. In: Khuntikeo, N., Andrews, R.H., Petney, T.N., Khan, S.A. (eds) Liver Fluke, Opisthorchis viverrini Related Cholangiocarcinoma. Recent Results in Cancer Research, vol 219. Springer, Cham. https://doi.org/10.1007/978-3-031-35166-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-031-35166-2_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-35165-5
Online ISBN: 978-3-031-35166-2
eBook Packages: MedicineMedicine (R0)